Enavatuzumab, a Humanized Anti-TWEAK Receptor Monoclonal Antibody, Exerts Antitumor Activity through Attracting and Activating Innate Immune Effector Cells
about
Enavatuzumab, a Humanized Anti-TWEAK Receptor Monoclonal Antibody, Exerts Antitumor Activity through Attracting and Activating Innate Immune Effector Cells
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Enavatuzumab, a Humanized Anti ...... g Innate Immune Effector Cells
@en
Enavatuzumab, a Humanized Anti ...... g Innate Immune Effector Cells
@nl
type
label
Enavatuzumab, a Humanized Anti ...... g Innate Immune Effector Cells
@en
Enavatuzumab, a Humanized Anti ...... g Innate Immune Effector Cells
@nl
prefLabel
Enavatuzumab, a Humanized Anti ...... g Innate Immune Effector Cells
@en
Enavatuzumab, a Humanized Anti ...... g Innate Immune Effector Cells
@nl
P2093
P2860
P50
P356
P1476
Enavatuzumab, a Humanized Anti ...... g Innate Immune Effector Cells
@en
P2093
Donghee Choi
Nicole A Belmar
Patricia A Culp
Stephen F Keller
Vivian Zhao
P2860
P304
P356
10.1155/2017/5737159
P577
2017-09-17T00:00:00Z